Metraipolis › archive › dc_fac7f0707442
Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200 — Europe PMC PMID:42798844
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42798844
- DOI
- 10.3389/fonc.2026.1933140
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T03:29:23.958Z
- SHA-256 of the archived text
2333dc5dbcafa2f4358bce24733c9439d67bcee9de7f4af0cc0bcdd86f30ebc3- Stable URL of this page
https://metraipolis.com/documento/dc_fac7f0707442
How to cite
Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200 — Europe PMC PMID:42798844 — Europe PMC (en), https://europepmc.org/article/MED/42798844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fac7f0707442 (Metraipolis archive dc_fac7f0707442, sha256 2333dc5dbcafa2f4358bce24733c9439d67bcee9de7f4af0cc0bcdd86f30ebc3)
BibTeX
@misc{dcfac7f0707442,
title = {Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200 — Europe PMC PMID:42798844},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42798844},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fac7f0707442; sha256 2333dc5dbcafa2f4358bce24733c9439d67bcee9de7f4af0cc0bcdd86f30ebc3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798844. Agents can read the archived copy with the MCP tool read_document.